Cardiovascular Devices Global Market Report 2020-30: COVID-19 Impact and Recovery from the publisher provides the strategists, marketers and senior management with the critical information they need to assess the global cardiovascular devices market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Description:
Where is the largest and fastest growing market for the cardiovascular devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cardiovascular Devices market global report from the publisher answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider cardiovascular devices market, and compares it with other markets.
Scope
Markets Covered:
1) By Type: Cardiovascular Surgery Devices And Equipment; Cardiac Rhythm Management (CRM) Devices And Equipment; Interventional Cardiology Devices And Equipment; Defibrillator Devices And Equipment; Peripheral Vascular Devices And Equipment; Prosthetic Heart Valve Devices And Equipment; Electrophysiology Devices And Equipment; Cardiac Assist Devices And Equipment
2) By End User: Hospitals And Clinics; Diagnostic Laboratories; Others
3) By Type of Expenditure: Public; Private
4) By Product: Instruments/Equipment; Disposables
Companies Mentioned: Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; Cardinal Health Inc; Edwards Lifesciences
Metrics Covered: Number of Enterprises; Number of Employees
Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, cardiovascular devices indicators comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:
Where is the largest and fastest growing market for the cardiovascular devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cardiovascular Devices market global report from the publisher answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider cardiovascular devices market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
- The cardiovascular devices market section of the report gives context. It compares the cardiovascular devices market with other segments of the medical equipment market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cardiovascular devices indicators comparison.
Scope
Markets Covered:
1) By Type: Cardiovascular Surgery Devices And Equipment; Cardiac Rhythm Management (CRM) Devices And Equipment; Interventional Cardiology Devices And Equipment; Defibrillator Devices And Equipment; Peripheral Vascular Devices And Equipment; Prosthetic Heart Valve Devices And Equipment; Electrophysiology Devices And Equipment; Cardiac Assist Devices And Equipment
2) By End User: Hospitals And Clinics; Diagnostic Laboratories; Others
3) By Type of Expenditure: Public; Private
4) By Product: Instruments/Equipment; Disposables
Companies Mentioned: Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; Cardinal Health Inc; Edwards Lifesciences
Metrics Covered: Number of Enterprises; Number of Employees
Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, cardiovascular devices indicators comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1. Executive Summary2. Report Structure7. Cardiovascular Devices Market Trends And Strategies20. Key Mergers And Acquisitions In The Cardiovascular Devices Market24. Copyright And Disclaimer
3. Cardiovascular Devices Market Characteristics
4. Cardiovascular Devices Market Product Analysis
5. Cardiovascular Devices Market Supply Chain
6. Cardiovascular Devices Market Customer Information
8. Cardiovascular Devices Market Size And Growth
9. Cardiovascular Devices Market Regional Analysis
10. Cardiovascular Devices Market Segmentation
11. Cardiovascular Devices Market Metrics
12. Asia-Pacific Cardiovascular Devices Market
13. Western Europe Cardiovascular Devices Market
14. Eastern Europe Cardiovascular Devices Market
15. North America Cardiovascular Devices Market
16. South America Cardiovascular Devices Market
17. Middle East Cardiovascular Devices Market
18. Africa Cardiovascular Devices Market
19. Cardiovascular Devices Market Competitive Landscape
21. Market Background: Medical Equipment Market
22. Recommendations
23. Appendix
Executive Summary
North America was the largest region in the global cardiovascular devices market, accounting for 37% of the market in 2019. Asia Pacific was the second largest region accounting for 24% of the global cardiovascular devices market. Africa was the smallest region in the global cardiovascular devices market.Demand for minimally-invasive cardiac surgeries is increasing as they are less disruptive and traumatic for the human body, and result in less post-surgical recovery time and improved efficiency. These techniques may be suitable for certain procedures involving the heart valves and certain types of routine bypass surgeries. For instance, robot assisted heart surgeries are more evident in mitral valve surgeries and heart surgeries. These surgeries are replacing traditional methods with larger incisions. In this procedure surgeons use a computer enhanced device to guide the surgical tools, which consist of robotically-guided arms that reach and operate in difficult-to-reach areas, and a robotically controlled 3D camera for visualization.
The cardiovascular devices (or) equipment market consists of sales of cardiovascular devices and related services by entities (organizations, sole traders and partnerships) that produce cardiovascular devices used in diagnosing and treating cardiovascular diseases. This industry includes establishments that produce devices such as cardiovascular surgery devices, cardiac rhythm management (CRM) devices, interventional cardiology devices, peripheral vascular devices, electrophysiology devices and other devices used in cardiovascular surgeries, treating arrhythmia and other cardiovascular diseases.
The global cardiovascular devices market is expected to decline from $53.6 billion in 2019 to $44 billion in 2020 at a compound annual growth rate (CAGR) of -18%. The decline is mainly because of the lockdown measures due to the COVID-19 outbreak. The decrease in the demand for cardiovascular devices due to decreased number of cardiac surgeries for reasons such as re-scheduling of surgeries, cancellations and no-show by patients, coupled with the restrictions by government and health authorities to shutdown factories manufacturing these devices to contain the spread of virus and keep the staff safe, contribute to this decline. The market is then expected to recover and grow at a CAGR of 7% from 2021 and reach $69.3 billion in 2023.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Cardinal Health Inc
- Edwards Lifesciences
Methodology
LOADING...